Professional Documents
Culture Documents
11
20
21
22
23
24
25
26
27
28
3 reasonable probability of success on the merits and irreparable harm. Using a selective and often
4 misleading recitation of allegations, Plaintiff Quid, Inc. (“Quid”) attempted to make that showing
5 in its opening papers with salacious allegations regarding the downloading of large number of
6 files, the illicit creation of a new company unbeknownst to his former employer Quid and abject
7 surprise at his continued access to his prior email account. Quid has mislead this Court as to the
8 true facts and circumstances here. No injunction is warranted and this case should be immediately
9 dismissed for purposes of mediation and arbitration. Taking each point in turn:
10 - The Alleged Downloads - The only downloads that Quid alleges Dr. Gourley executed
11 occurred during his employment and thus do not support trade secret misappropriation. Quid
13 employment. Dr. Gourley has provided a sworn declaration he did not access or use any Quid
14 proprietary information after he left Quid’s employ. Ongoing forensic expert analysis of Dr.
15 Gourley’s devices is consistent with Dr. Gourley’s declaration on this point, indicating that he
16 has not accessed any of these materials since 2012, long before his Quid employment ended.
17 - The Alleged Trade Secrets - Quid fails to identify or show any protectable trade secrets
18 whatsoever, as is its burden. Expert analysis confirms that none of what Quid identifies is a
19 protectable trade secret or even confidential. For example, one of the “86 python files” that
21 Moreover, much of Quid’s software algorithms and techniques are disclosed in its own public
22 patents and thus cannot be trade secrets. Quid’s customer lists and investors are similarly not
23 trade secrets—they are publicly disclosed on the internet too. And arguing for a non-
24 solicitation injunction based on Dr. Gourley’s contract is prohibited by Section 16600 under
25 California law. Finally, though just as importantly, Quid’s trade secret and related contract
26 claims also cannot succeed because they are barred by the statute of limitations.
27 - Forming Primer - Quid claims surprise at Gourley’s founding of Primer during the time of
28 his transition agreement and before his termination in 2015. It cannot credibly do so. Gourley
2 that he would be able to seek other employment during this time period. Moreover, Neville
3 Crowley, who later became Quid’s CEO, knew about and was participating in the formation
4 of Primer at this same time. Quid included a declaration from Mr. Goodson stating he was
5 unaware of Dr. Gourley’s activities, but Quid concealed from this Court the knowledge of the
6 company as a whole, including the future Quid CEO Mr. Crowley, who knew about the
8 - Dr. Gourley’s Quid.com Email Account Access - This is another instance where Quid’s
9 feigned surprise is contrary to the facts and its own knowledge. Quid again puts in a
10 declaration from Mr. Goodson expressing surprise that Dr. Gourley still had access to his
11 quid.com email address, but fails to inform the Court that the former CEO negotiated
12 continued access for Dr. Gourley’s to his quid.com email account. Dr. Gourley was paid a
13 sales commission by Quid after his termination as part of that same agreement. That Quid
14 never turned off email access does not at all affect their consent. Moreover, for several of the
15 emails that Quid claims were “misdirected” by Dr. Gourley, those emails were actually sent to
17 They were never “Quid opportunities” in the first place, though Quid attempts to mislead the
18 Court in thinking they are. For several others, they are relationships built by Dr. Gourley
19 independent of his work at Quid and again not any opportunities that are the property of Quid.
20 Quid ambushed Primer and the defendants with a motion for a temporary restraining order
21 with only hours to prepare, even though Quid itself took months to prepare its allegations. This
22 highly prejudiced the defendants in the process. Primer now responds to the motion put forth by
23 Quid and has fully demonstrated that Quid is not entitled to any injunctive relief because of its
24 lack of evidence, among other reasons. Quid cannot now be permitted to submit additional
25 evidence in its response as that would be yet another ambush violating basic principles of due
26 process.
27 Finally, and most egregiously, Quid either was negligent in failing to discover or
28 intentionally hid from the Court that Quid and Gourley specifically negotiated and agreed that
7 Decl. ¶ 7; Gourley Decl. at ¶ 6. On June 23, 2008, it retained Sean Gourley as a consultant to
8 develop a startup database that analyzed the companies as they grew. Gourley Decl. at ¶ 6. At
9 that time, Dr. Gourley was serving as a post-doctoral researcher at Oxford University where he
10 was developing open source data monitoring tools for international conflict zones. Id. at ¶ 2. He
11 had recently obtained his PhD in physics from Oxford, which he attended on a Rhodes
12 Scholarship. Id.
13 You Noodle was impressed with Dr. Gourley’s initial work for them and hired him full-
14 time on or around January 11, 2009. Id. at ¶ 6. As Dr. Gourley’s work progressed, it became
15 clear that his analytical tools were becoming a more promising product than the company’s social
16 network. Id. at ¶ 7. His initial work analyzing startups had grown into a product which could be
17 used to ingest large amounts of written information and analyze the relationships between the
18 concepts discussed within. Id. at ¶¶ 6-7. Specifically, the product produced visual diagrams and
19 charts that show which of the topics selected by a user were often related to each other (and which
20 were related more often than others). Id. By Spring 2010, the founders and board decided to
21 divide the business and center the company around Dr. Gourley’s work. You Noodle would
23 Quid launched in or around the week of September 15, 2010. Id. at ¶ 8. As more and
24 more companies tested the product it started gaining traction. Id. By March 2011, Dr. Gourley
25 published an article describing Quid’s startup predictor in the Harvard Business Review. Id. at
26 ¶ 9, Ex. A. This article included a chart showing how Quid’s software analyzed data and output a
27 graphic showing the relationship between the topics in the articles that the user selects for analysis.
28 Id.
2 meeting. App. at 12. Quid omits several important facts and paints a misleading picture regarding
3 that event and timeframe. Although the technical components of Quid were successful, it had
4 financial difficulties during this time period. Gourley Decl. at ¶ 10. Quid had a significant “burn
5 rate” and by late 2011 was running out of money. Id. The board blamed CEO Bob Goodson for
6 the lack of budgeting and demanded monthly financial reports. Id. This was one of the primary
7 topics in the January 16, 2012 board meeting where the consensus was that the business side of the
8 company needed to be reformed. Id. It was during this same meeting that Dr. Gourley
9 demonstrated the functioning of Quid’s new software to the board. Id. at ¶ 11. After the meeting,
10 Mr. Goodson was demoted and relieved of his duties as CEO.1 The board then began the search
11 for a new CEO. Id. They located Kevin Freedman in February and he took the position in March
12 2014. Mr. Goodson was demoted to Chief Revenue Officer. Id. at ¶ 12.
13 As for Dr. Gourley, far from “fail[ing]” as Quid suggests, on March 20, 2012 he presented
14 the same technology he had presented to the board publicly at a “Data Driven NYC” event. Id. at
15 ¶ 11. The technology, which largely mirrors Quid’s functionality today, worked. Id. Moreover,
16 after Mr. Freedman was named CEO, Quid awarded Dr. Gourley a significant bonus and pay
18 B. Quid’s Leadership Crisis Prompts Dr. Gourley to Exit Quid While Continuing to
Work With its Officers on New Projects and Fundraise for the Company.
19
Despite the technical successes, Quid’s management remained a problem. Dr. Gourley
20
decided to take action and in June 2014 met with the Chairman of the Board Charles Lho to
21
discuss his concerns. Id. at ¶ 15-16. While the board reviewed Mr. Freedman’s performance, Mr.
22
Freedman decided to terminate Dr. Gourley. Id. at ¶ 17. However, because Dr. Gourley was such
23
an integral member of the company, they decided that the termination would be gradual so that he
24
could continue to help Quid with sales and fundraising while seeking new projects. Id. at ¶ 18-19.
25
When Dr. Gourley received an initial draft of this “Transition Agreement,” it included an
26
27
Mr. Goodson, who provides a declaration in support of Quid’s motion, stayed on at Quid.
1
28 After two other CEOs had the job and left, Mr. Goodson again took the position.
2 disclosure of a party’s private, confidential, propriety or trade secret business information. Id. at
3 ¶¶ 20-21. In response, Dr. Gourley wrote a letter to Kevin Freedman, then CEO of Quid,
5 If I help in the transition, I don’t want to find myself in a position several months
later whereby Quid tries to keep me out of the industry by asserting that my skill
6 set, knowledge and/or new inventions are somehow Quid trade
secrets. Consequently, I would want an understanding with the company that I
7 would not be impeded in the pursuit of a new career based on my skills. If
questions arise with respect to trade secrets or IP, we should have a procedure
8 whereby any issues can be quickly and fairly presented and resolved in
confidence with a quick arbitration if necessary.
9
Id. at ¶¶ 20-21 and Ex. E (emphasis added).
10
Dr. Gourley then sent back a revised version of the Transition Agreement with revised
11
arbitration provisions, consistent with the statements in his letter. Id. Notably, that version
12
removed the language permitting either party to seek injunctive relief in court for trade secret
13
business information. Id. Instead, it included a broad arbitration provision that states that all
14
disputes, “including the availability of injunctive or other equitable relief, shall be resolved
15
exclusively through binding arbitration.” Id.
16
The transition agreement also expressly contemplates that Gourley will be permitted to
17
pursue new ventures during this time. Id. at ¶ 20, 83; Goodson Decl. Ex. E at 1 (“These Transition
18
Duties are not expected to require your daily or full-time attendance at the office, and you may
19
take time off from. your Transition Duties to seek other employment so long as your Transition
20
Duties are timely completed at a satisfactory or better level of performance.”) Eight weeks after
21
this agreement is entered the board terminated Quid CEO Freedman. Gourley Decl. at ¶ 17.
22
C. Dr. Gourley Develops Primer With The Future CEO of Quid, Neville Crowley
23
When Dr. Gourley was expressly allowed to seek other employment under the Transition
24
Agreement, Dr. Gourley began creating Primer. Id. at ¶¶ 24-29. His original partner in these
25
efforts was Neville Crawley, then COO of Quid. Id. at ¶¶ 24-25. Together they discussed
26
Primer’s business plan and solicited investors. Id. at ¶ 24-26; see Dauber Decl. at ¶¶ 6-8. Mr.
27
Crawley did not join Primer because several weeks into these discussions he was offered the CEO
28
2 assuming the role. Id. at ¶ 27. He also sought to keep Dr. Gourley involved in Quid, even after
3 the January 15 date listed in the termination agreement, so that he could continue to help the
4 company bring in business. Id. He offered Dr. Gourley 10% of the revenue from any sales he
5 brought in. Id. at ¶ 34. Accordingly, when Dr. Gourley’s employment with Quid ended on
6 January 15, 2015 he requested that his e-mail access be extended. Id. He met with Mr. Crawley
7 and they agreed to extend it. Several Quid officers, board members, and employees sought Dr.
8 Gourley’s assistance at this e-mail address months after the originally anticipated January 15,
9 2015 termination date. When Quid implemented two-factor authentication for its e-mail in 2016 it
10 provided Dr. Gourley with new credentials to continue accessing his Quid email. Id. at ¶ 41.
11 As Dr. Gourley used this e-mail address, he made it clear to customers that he was no
12 longer a full-time employee of Quid. Id. at ¶ 82. When he was asked about his current work or
13 Primer, he explained that it was his new venture. Id. at ¶¶ 36, 79. Dr. Gourley did not arrange for
14 any investors who e-mailed him about Quid to invest in Primer. Id. at ¶¶ 44, 78, 84. And all of
15 Primer’s investors fully understood that this was Dr. Gourley’s company, not part of Quid. Id. at
16 ¶ 84.
20 visual diagrams and charts that show which topics which are often related to each other (and in
21 some instances identify key words). Id. at ¶¶ 52-61. Primer’s technology, by contrast, compares
22 all information provided by the sources and writes summaries synthesizing all key information.
23 Id. The two pieces of software are used for different purposes and the use of one does not reduce
24 demand for the insights which can be provided by the other. Id. Accordingly there have been no
25 customers who Dr. Gourley convinced to buy Primer over Quid. Id. at ¶ 61.
26 E. Dr. Gourley Did Not Access Quid’s Product Files After Leaving the Company.
27 Following his departure Dr. Gourley did not access or use any Quid proprietary
28 information. Id. at ¶¶ 62-77. Because of the volume of data, the processing and analysis is
2 account but did not access any locations where product or technical information would be stored.
3 Bui Decl.at ¶¶ 6-12. It similarly indicates that Dr. Gourley did not access any of the contents of
7 of UC Irvine. He has analyzed all the evidence provided by Quid in its opening papers. None
8 comprise trade secrets. Smyth Decl. at ¶¶ 3-6, 13, 20-43. All the technical information Quid
9 purports to identify reflects broad concepts and techniques that are publicly known. Id.
10 Consistent with this, Quid publishes much of its technical information in articles and its own US
14 and beyond the allegations made by Quid, to ensure that no Quid proprietary information is used
15 in developing Primer and that no Quid confidential information is in the possession of Primer or
16 its employees. In the course of its investigation, it uncovered that Ms. Heineke and Dr. Yera may
17 have some old Quid files from their prior employment. Ms. Heineke does not recall ever
18 accessing these files since she joined Primer. Heineke Decl. at ¶ 6. As discussed below, Mr. Yera
19 does not recall accessing them since early 2015. Yera Decl. at ¶¶ 6-9. Ms. Heineke and Dr. Yera
20 immediately provided these devices to Primer’s forensic consultants who are imaging the devices,
21 segregating and quarantining any Quid data. Id. Any files are now no longer in Ms. Heineke and
22 Dr. Yera's possession. Id. Primer will immediately return to Quid any Quid files if located.
23 Primer also learned, as discussed in Dr. Yera's declaration, that he may have used a Quid
24 file in early 2015 to locate four numbers when beginning his work at Primer. Yera Decl. at ¶¶ 6-9.
25 He did so as a matter of convenience, even though he could have derived the numbers himself
26 based on public source code and scientific papers. Id. Because these numbers can be derived
27 from generally known techniques they are not trade secrets. Regardless, with the exception of one
28 number that is publicly available, these numbers were long ago removed from Primer’s code and
2 looked at or used any Quid proprietary information in her work at Primer. Heineke Decl. at ¶ 6.
3 Even though Dr. Yera or Ms. Heineke’s were not alleged to have retained any files by
4 Quid in its motion or even in its complaint, Primer does not want any Quid files or proprietary
5 information at Primer and thus took these extra steps in the last week. No Quid information
9 absent an injunction. Costa Mesa City Employees' Assn. v. City of Costa Mesa, 209 Cal. App. 4th
10 298, 305-06 (2012), as modified (Oct. 10, 2012). After making a showing of irreparable harm,
11 Quid must then establish that (1) its claims have a “reasonable probability” of prevailing on the
12 merits and (2) an injunction will avoid more injury than it will cause. Cont'l Baking Co. v. Katz,
13 68 Cal. 2d 512, 528 (1968) (citations omitted). Quid has “the burden of presenting facts which
14 show a reasonable probability” that its trade secret claims will prevail at trial. Citizens for Better
15 Streets v. Bd. of Supervisors, 117 Cal. App. 4th 1, 6 (2004) (emphasis added).
16 IV. ARGUMENT
17 A. THIS COURT LACKS JURISDICTION BECAUSE OF A CLEAR
ARBITRATION CLAUSE
18
As discussed in Primer’s petition to compel arbitration, this Court lacks jurisdiction and
19
thus there is no likelihood of success on the merits. Gourley and Quid negotiated and agreed to
20
arbitration provision for the express purpose of dealing with these type of claims. Gourley Decl. at
21
¶¶ 20-22, Ex. E. Even the question of arbitrability is subject to arbitration. Greenspan v. LADT,
22
LLC, 185 Cal. App. 4th 1413 (2010). That Quid did not disclose this history either demonstrates
23
negligence or an intent to hide the facts from the Court. The Court should decide (and grant) the
24
motion to compel arbitration first, avoiding any need to address the motion for injunctive relief.
25
B. QUID HAS NOT SHOWN PRIMER OR SEAN GOURLEY
26 MISAPPROPRIATED TRADE SECRETS.
27 Misappropriation of trade secrets requires unauthorized disclosure, unauthorized use, or
28 acquisition by improper means. Cal. Civ. Code § 3426.1. Mere possession does not constitute
2 Inc. v. Parrish, 174 Cal. App. 4th 1270, 1279 (2009) (“possession of trade secrets by a departing
3 employee is not enough for an injunction[,]” particularly where the employee did not retain the
4 alleged trade secrets). Id.. As all elements of its claims, Quid has the burden to produce evidence
5 showing that it is likely to prevail on misappropriation. This burden can only be satisfied with
6 evidence, not mere speculation about possible wrongful conduct. See Costa Mesa, 209 Cal. App.
7 4th at 305 and Citizens for Better Streets v. Bd. of Supervisors, 117 Cal. App. 4th at 6.
8 Quid’s only evidence of purported trade secret misappropriation only suggests that Dr.
9 Gourley copied files during his employment. Kaderabek Decl. at ¶¶ 6-8; Compl. ¶¶ 51-54, 57-61
10 (alleging that he made copies on two or three occasions prior to his termination date).2 While the
11 analysis is ongoing, current forensic evidence indicates that Dr. Gourley has not accessed any of
12 these files after he was employed at Quid. Bui Decl. at ¶¶ 6-12. All of Dr. Gourley’s relevant
13 devices are also in the possession of Primer’s forensic experts, not Dr. Gourley. Bui Decl. ¶ 3;
14 FLIR Sys., Inc., 174 Cal. App. 4th at 1278-80 (finding that no injunction can issue when the
16 Quid’s application and Mr. Goodson Declaration include assertions that Dr. Gourley
18 reference any observation or technical information supporting such an inference (or the first-hand
19 knowledge of any witness or content of any document).3 See Bui Decl. at ¶ 13. The absence of
20 evidence is telling. If Dr. Gourley had continued to log in to applications containing Quid
21 technical information, Quid would be able to readily confirm that with user log data. Ibid.
22
23
2
But even if Dr. Gourley had copied these files, on all three of those occasions Dr. Gourley was
24 a Quid employee utilizing his files saved in his employee accounts. Quid has not alleged that he
wrongfully used or disclosed them on those occasions.
25
3
Quid’s unsupported suggestion that Dr. Gourley was monitoring Quid’s Google applications
26 during the very hour when they cancelled his account in October 2018 lacks credibility even on its
own terms. It is also readily explained by the fact that Dr. Gourley’s e-mail was connected to his
27
phone, which immediately and automatically alerted him that it could no longer synch with one of
28 his e-mail accounts. Gourley Decl. at ¶¶ 42-43.
2 application seems to ask this Court to infer use from the fact that Primer is a company that also
3 produces machine learning technology. This conclusory assertion is wrong because the products
4 work differently and serve different purposes. Quid’s outputs visual diagrams and charts that
5 show which topics in a data set which are often related to each. See Smyth Decl. ¶ 20. Primer’s
6 technology, by contrast, compares the information provided by each source different sources, and
7 writes human readable executive summaries synthesizing all key information available. Id. ¶ 21.
8 Even if Primer’s technology was generally similar, the inference Quid seeks invites only
9 error. It constitutes a thinly-veiled attempt to use the inevitable disclosure doctrine in support of a
10 trade secret injunction, a doctrine that has been flatly rejected in California. Whyte v. Schlage
11 Lock Co. (2002) 101 Cal. App. 4th 1443, 1462 (citing Bus. & Prof. Code, § 16600, and cases
12 applying it). The fact that Primer is also an artificial intelligence company is insufficient to
13 support any actual or threatened use of trade secrets under California law. Whyte, 101 Cal. App.
14 4th 1461-1462.
15 Dr. Gourley’s e-mails also do not justify an inference that trade secrets were available for
16 download (or copied or used). Quid seeks to use Dr. Gourley statements about the relationship
17 between Quid and Primer to characterize how Primer’s technology was developed. But the
18 connections Quid draws rely on mischaracterizations and in some instances misquote the e-mails.
19 In one instance, Quid quotes an e-mails in which Dr. Gourley used the word “we” but replaces it
20 with “[Quid]” even though the e-mail makes no reference to Quid and Dr. Gourley is undeniably
21 talking about Primer. App at 14:12-13; Goodson Decl. Ex L. In another, Quid cites a $1.1 million
22 sale that Dr. Gourley negotiated for Quid as an instance of him “using Quid confidential
23 information to benefit Primer.” App at 15, fn. 8; Goodson Decl. ¶ 36, Ex. W. The basis for this
24 incorrect claim seems to be that, years after the negotiation, Dr. Gourley forwarded the contract
25 from his Quid account to his Primer account. Id.. But he only did this after later finding out Quid
26 underpaid him the sales commission he was entitled to. Gourley Decl. ¶ 36. Quid and Mr.
27 Goodman also mischaracterize the relationship between parties, calling an individual who Dr.
28 Gourley met at an academic event who tried to hire Sean post-termination an “existing and
2 description to a businessman who Dr. Gourley knew independent of Quid but met with in 2015
3 and tried to sell Quid products to after his formal termination. Goodson Decl. ¶¶ 29-30, Ex H;
4 Gourley Decl. ¶ 36, 87. In several other instances, Quid omits the first or last e-mail in the chain,
5 showing that the conversation was initiated by Dr. Gourley’s personal e-mail or by another party.
6 Gourley Decl. ¶¶ 36, 38. These mischaracterizations highlight a pattern of misrepresenting Dr.
7 Gourley’s words and conduct where what he really said and did does not fit Quid’s narrative.
8 Quid and Mr. Goodson also attempt to mislead this Court by (falsely) suggesting that
9 Primer was hiding from Quid, hoping again to justify an inference of wrongdoing. After quoting a
10 string of 2015 e-mails Mr. Goodson declares that “[t]hroughout the relevant time period, Gourley
11 kept his efforts hidden from Quid by, among other things, operating in a self-described ‘stealth
12 mode’ until his product was ready for launch.” Goodson Decl. at ¶ 41. But Mr. Goodson knew of
13 Primer and its development. He texted Dr. Gourley in December 2015 to congratulate him on
14 Primer’s “progress” which he was “glad to hear about.” Id. at Ex. BB. Mr. Crowley, then Quid’s
15 CEO, also knew all about Primer, having once been a potential co-founder. Given the extent of
16 Quid’s misrepresentations, its various stories about Primer should not be allowed to substitute for
20 particularity” at the outset of litigation. Code Civ. Proc., § 2019.210. This rule was adopted to
21 “promot[e] well-investigated claims and dissuad[e] the filing of meritless trade secret complaints.”
22 Perlan Therapeutics, Inc. v. Superior Court, 178 Cal. App. 4th 1333, 1343 (2009).
23 Notwithstanding this, and Quid’s claims at the March 28 hearing that it waited several months to
24 apply for a temporary restraining order so that it could “investigate” alleged downloads,4 Quid’s
25
26
Quid admits it has known since at least October 2018 that Primer’s founder still had access to
4
27
his old Quid email and Google Suite accounts. Goodson Decl. ¶ 47; Reed Decl. ¶¶ 4-5. Quid
28 further admits it has known about the forensic activity that supposedly forms the basis for the
2 not identify or describe a single specific piece of commercial information which qualifies as a
3 trade secret.
4 Trade secret claims pled without reasonable particularity cannot justify a preliminary
6 12564011, at *4 (C.D. Cal. Aug. 11, 2014) (denying preliminary injunction because the court
7 could not “see how a plaintiff can carry its heavy burden [to justify the injunction] without
8 specifying what, exactly, it is trying to protect”). See also Religious Tech. Ctr. v. Netcom On-Line
9 Commc'n Servs., Inc., 923 F. Supp. 1231, 1252 (N.D. Cal. 1995). Here Quid has simply suggested
10 that because there are documents allegedly kept confidential that may have been copied, trade
11 secrets must have been taken and misappropriated. But absent identification of the trade secrets in
12 those documents there is no claim upon which litigation can begin. See Via Techs., Inc. v. Asus
13 Comp. Int'l, 2016 WL 1056139, at *3 (N.D. Cal. Mar. 17, 2016) (finding that a reference to “3300
14 pages [that] are simply whatever [plaintiff’s] employees printed before they left” did not identify a
15 trade secret); Perlan Therapeutic, 178 Cal. App. 4th at 1351-2 (holding that the identification must
16 segregate the claimed trade secrets from accompanying public information); Jobscience, Inc. v.
17 CVPartners, Inc., 2014 WL 93976, at *5 (N.D. Cal. Jan. 9, 2014) (finding identification of
20 present defenses, like arguing that the claimed information is already in the public domain. This is
21 a crucial question because all of the information allegedly copied was from 2015 and prior. Supra
22 § III(B). Since 2015, a litany of events have likely extinguished any potential trade secrets. Chief
23 among them are Quid’s own patent applications. App. at 10:2-4 (Quid’s “innovations. . . are the
24 subject of issued United States patents”); Stutz Motor Car of Am., Inc. v. Reebok Int'l, Ltd., 909 F.
25 Supp. 1353, 1359 (C.D. Cal. 1995), aff'd, 113 F.3d 1258 (Fed. Cir. 1997) (“disclosure of
26 a trade secret in a patent places the information comprising the secret into the public domain . . .
27
present request for expedited relief since at least January 2019. Goodson Decl. ¶¶ 51-52; Reed
28 Decl. ¶¶ 6-9.
2 thereby disclosing the processes and techniques which its software employs.5 Goodson Decl. at
3 ¶¶ 7, 21. However since Quid has not identified what information is claimed as a trade secret,
4 Primer cannot show that the relevant information is public. This leaves “the most important
5 consideration” in a trade secret case unexamined. Lehman v. Dow Jones & Co., 783 F.2d 285, 298
7 Primer has retained Dr. Smyth to look at the limited information that Quid has identified
8 as trade secrets in its opening motion. Smyth Decl. at ¶¶ 3-6, 13, 20-43. Looking at all the
9 information that Quid has provided, he cannot identify any information that would qualify as a
10 trade secret. Id. He also has identified a broad set of technical information describing Quid’s
11 algorithms, product and internal software information. Id.; Gourley Decl. Ex. A.
12 In these circumstances, Quid has not shown that these claims have any likelihood of
13 success. Action Learning Sys, 2014 WL 12564011, at *4 (quoting Altavion, Inc. v. Konica
14 Minolta Sys. Lab. Inc., 226 Cal. App. 4th 26, 43 (2014)) (“Until the content and nature of the
15 claimed [trade] secret is ascertained, it will likely be impossible to intelligibly analyze the
16 remaining elements that constitute the cause of action.”) (emphasis added) As revealed at the
17 March 28 hearing, Quid made a strategic decision to spend months investigating the alleged
18 copying of its files before seeking an injunction. Its contrasting “refusal to pin down in argument
19 the specific nature of the information it claims to own” shields the other elements of its claim from
20 scrutiny, raising serious questions about the strength of its case. See Swarmify, Inc. v. Cloudflare,
21 Inc., No. C 17-06957 WHA, 2018 WL 1142204, at *3 (N.D. Cal. Mar. 2, 2018) (expressing
22 skepticism of the merits of trade secret claims which are too amorphous to assert defenses against,
23 while a denying preliminary injunction on other grounds) (emphasis added). Quid cannot be
24
5
25 See Silvaco Data Sys. v. Intel Corp., 184 Cal. App. 4th 210, 221-22, 109 Cal. Rptr. 3d 27, 39
(2010), as modified on denial of reh'g (May 27, 2010), and disapproved of by Kwikset Corp. v.
26 Superior Court, 51 Cal. 4th 310, 246 P.3d 877 (2011), and disapproved of by Swarmify, Inc. v.
Cloudflare, Inc., No. C 17-06957 WHA, 2018 WL 1609379 (N.D. Cal. Apr. 3, 2018) (holding that
27
the design of a computer program being sold publically is not a trade secret where the process
28 becomes evident to anyone using the program).
2 Primer would not have had an opportunity to respond to the allegations. See Proctor v. Vishay
3 Intertechnology, Inc. 213 Cal.App.4th 1258, 1274 (2013). With the central elements of its claims
4 shrouded in mystery, Quid cannot satisfy its burden of showing that it is likely to prevail on the
5 merits.
6 Quid’s failure to identify trade secrets also denies the Court the foundation for a proper
7 injunction. Action Learning Sys, 2014 WL 12564011, at *4. Without knowing what Quid’s trade
8 secrets are, the Court cannot craft an order which defines the prohibited activities. A prohibition
9 on activities associated with unspecified trade secrets would be too vague to enforce. See In re
10 Berry, 68 Cal. 2d 137, 155-7 (1968) (finding that an injunction must be specific and
12 potential impact on third-party customers, vendors, and investors underscores that any Court order
13 should be able to stand on its own, clearly delineating what conduct is prohibited.
23
24 6
See https://quid.com/feed/ recapping-our-biggest-customer-event-yet-quid-explore-london
(“The day began with presentations from Quid experts at Siemens, Accenture, University College
25
London, CNC, Ketchum, and Bite Global who all shared how they’re harnessing the power of
26 Quid for their organizations.); see also https://quid.com/feed/quid-helps-walmart-build-the-
american-family-today-report (discussing Walmart as Quid customer);
27 https://quid.com/feed?category=from-our-clients.
7
28 See https://en.wikipedia.rg/wiki/Quid_Inc.#Customers.
2 available and awarding attorneys’ fees). See also Cal. Civ. Code. §3426.1(d)(2).
3 Quid’s investors are similarly routinely identified by name in company press releases
4 following successful fundraising rounds. See, e.g., McCauley Decl. Ex. A. News and industry
5 commentary also confirm that the identity of Quid’s investors is public knowledge. McCauley
6 Decl. Exs. B, C. This eliminates the possibility of trade secret protection. The Ret. Grp. v.
8 The identities of Quid’s investors further cannot be trade secrets as a matter of law. A
9 trade secret must be information which a company owns and profits from. CytoDyn of New
10 Mexico, Inc. v. Amerimmune Pharm., Inc., 160 Cal. App. 4th 288, 297 (2008). A company cannot
11 hold the required property interest in the identity of its investors, or profit from them. Rather it is
12 the investors who own the property interest in and profit from the company. Accordingly,
13 investors and “ideas regarding who to approach as an investor . . . cannot be trade secrets.” Boyd
14 v. Univ. of Illinois, No. 96 CIV 9327 TPG, 2001 WL 246402, at *6 (S.D.N.Y. Mar. 13, 2001).
15 Even if a small customer or reclusive investor is not publically known, this pattern of
16 disclosure shows that Quid has not consistently safeguarded this information as required by
17 California law. Cal. Civ. Code. §3426.1(d)(2); In re Providian Credit Card Cases, 96 Cal. App.
18 4th 292, 308 (2002). Quid’s customers and investors are not trade secrets.
19 E. QUID CONSENTED TO GOURLEY’S CONTINUED EMAIL USE.
20 Dr. Gourley openly discussed Primer with Quid officers before leaving the company and
21 used his Quid e-mail afterwards because they asked him to continue to represent Quid. Following
22 the negotiation of his transition agreement, Dr. Gourley and Mr. Neville Crawley (Quid’s COO at
23 the time) began planning to launch a new business. Gourley Decl. at ¶¶ 24-28. They discussed
24 specific ideas for Primer’s technology, products, structure, and fundraising. Id. Mr. Crawley
25 prepared a list of investors to reach out to about the company, and spoke with several. Id. Mr.
26 Crawley ultimately did not join Primer because he was offered the position of CEO of Quid. Id.
27 But he remained supportive of the company and Dr. Gourley, who asked to continue to help Quid
28 with sales while working on setting up Prime. Id. Dr. Gourley and Mr. Crawley also met with
2 Dr. Gourley’s regular employment with Quid ended). Id. at ¶ 48. They discussed Primer and Mr.
3 Lho asked if he could invest in the company. Dr. Gourley declined but he and Mr. Lho continued
4 to discuss Primer’s progress over the next several years. Id., Ex. AA.
5 Quid knew about and effectively ratified Dr. Gourley’s conduct. On the termination date
6 outlined in his transition agreement Dr. Gourley and CEO Crawley agreed to leave Dr. Gourley’s
7 e-mail account open for 6-12 months so that he could continue conversations with and
8 “converting” potential clients, existing clients, and recruits for Quid. Goodson Ex. F; Gourley
9 Decl. at ¶¶ 30-42. Dr. Gourley was paid sales commissions by Quid after his termination as part
10 of that same agreement. Gourley Decl. at ¶¶ 34, 36, Ex. L. Meanwhile, Quid officers and
11 employees continued to contact him at his Quid e-mail address to discuss these matters. Id. at
12 ¶ 35. When Quid implement two-factor authentication in 2016 Dr. Gourley was informed,
13 successfully registered, and received credentials. That Quid never turned off email access until
17 California’s Uniform Trade Secrets Act (“CUTSA”). Cal. Bus. & Prof. Code § 17200 and 3426.
18 Quid’s application only argues that it will prevail on its UCL claim because Primer allegedly
19 misappropriated proprietary information. App. at 21:19-22:4. But in California, “CUTSA
20 provides the exclusive civil remedy for conduct falling within its terms, so as to supersede other
21 civil remedies ‘based upon misappropriation of a trade secret.’” Silvaco Data Sys. v. Intel Corp.,
22 184 Cal. App. 4th 210, 236 (2010) (quoting Cal. Civ. Code § 3426.7(a), (b)); see KC Multimedia,
23 Inc. v. Bank of Am. Tech. & Ops., Inc., 171 Cal. App. 4th 939, 954 (2009) (holding that CUTSA
24 “occupies the field in California” with respect to “alternative civil remedies based on trade secret
25 misappropriation”). CUTSA’s preemptive effect extends to UCL causes of action that are based
26 on trade-secret misappropriation. Silvaco, 184 Cal. App. 4th at 241 (“CUTSA bars UCL claims
27 sounding in misappropriation of trade secrets.”); KC Multimedia, 171 Cal. App. 4th at 961 (same).
28 This there is no separate UCL claim which Quid can prevail on.
3 Dr. Gourley largely arise from restrictions on the use of “proprietary information.” Section 8 of
5 discussed above, Quid has identified no confidential information that Gourley has
7 and patent filings operates as defenses to these claims as well. Supra at § III(C). And even if this
8 information had been copied by Dr. Gourley pre-termination, Quid offers no evidence to support
9 its assertion that he “disclose[d]” or “use[d]” it post-termination. Second, the other provisions of
10 the agreement, which Quid argues preclude Dr. Gourley from soliciting Quid clients and
11 employees cannot be enforced in such a manner under California law.8 Barker v. Insight Glob.,
12 LLC, No. 16-CV-07186-BLF, 2019 WL 176260, at *3 (N.D. Cal. Jan. 11, 2019) (“California law
14 AMN Healthcare, Inc. v. Aya Healthcare Servs., Inc., 28 Cal. App. 5th 923, 936 (Ct. App. 2018))
15 (same) (citing Edwards v. Arthur Andersen LLP, 44 Cal. 4th 937, 942, 947-948 (2008).
16 Moreover, Quid waived any right to enforce relevant portions of its confidentiality
17 agreement. The party who can enforce a contractual provision relinquishes its right to do so by
18 words or conduct “so inconsistent with an intent to enforce the right as to induce a reasonable
19 belief that such right has been relinquished.” Wind Dancer Prod. Grp. v. Walt Disney Pictures, 10
20 Cal. App. 5th 56, 78-81 (Ct. App. 2017). Here, although the confidentiality agreement purported
21 to require Dr. Gourley to return and relinquish access to company e-mail and online resources
22 upon termination, Quid’s conduct consistently indicated that it did not expect him to do so. This
23 pattern began on the termination date, when Dr. Gourley asked CEO Crawley to leave his e-mail
24 account open for 6-12 months so that he could continue conversations with and “converting”
25 potential clients, existing clients, and recruits for Quid. Goodson Ex. F; Gourley Decl. ¶¶ 32-36.
26
8
The confidentiality agreements were only signed by individual employees and not by Primer.
27
Quid does not argue that Primer is bound by this contract, nor could it. Thus this claim cannot
28 justify an injunction against Primer.
2 investors, paying him commissions on new investments which he brought to Quid. Ibid. All of
3 this conduct is irreconcilable with the alleged expectation that Dr. Gourley disconnect his
4 company e-mail on January 15, 2015. Quid was effectively paying him to continue using it
5 through 2016. In these circumstances, the company has relinquished any claim to enforce these
9 Trade secret claims must be brought within three years of the alleged conduct and breach of
10 contract and unfair competition claims must be brought within four years. Cal. Civ. Code
11 § 3426.6; Cal. Civ. Proc. § 337; Cal. Bus. & Prof. Code § 17208. Quid’s declarations only allege
12 that data was copied in or before January, 2015. Supra at § III(B). Quid had notice of these
13 claims immediately, because its own CEO, officers, and employees knew that Dr. Gourley
14 retained access to Quid’s Google Suite and was utilizing his Quid e-mail. Supra at § III (E and G);
15 Jolly v. Eli Lilly & Co., 44 Cal. 3d 1103, 1109-11 (1988). Quid’s vague and conclusory allusions
16 of monitoring after January, 2015 have no evidentiary support and therefore cannot resurrect these
17 claims or justify an injunction. Ibid.. There is thus no tenable claim which can succeed at all.
2 establishes a lack of irreparable harm that is, on its own, a sufficient basis to deny the injunctive
3 relief.” Oren Enterprises, Inc. v. Stefanie Cove & Co., No. CV 17-3619 PA (AFMX), 2017 WL
4 8220230, at *5 (C.D. Cal. June 2, 2017) (denying injustice relief against a former employee
5 alleged to have copied electronic files containing trade secrets before departing the company);
6 Way.com, Inc. v. Singh, No. 3:18-CV-04819-WHO, 2018 WL 6704464, at *11 (N.D. Cal. Dec. 20,
7 2018) (same for four plus month delay). Here, where Quid knew or should have known of Dr.
8 Gourley’s email access for years after his termination, Quid cannot show irreparable harm.
9 “Mere injuries, however substantial, in terms of money, time and energy necessarily
10 expended . . . are not enough. The possibility that adequate compensatory or other corrective relief
11 will be available at a later date . . . weighs heavily against a claim of irreparable harm.” Qualcomm
12 Inc. v. Compal Elecs., Inc., 17-CV-01010, 2017 WL 3967289, at *7 (S.D. Cal. Sept. 7, 2017).
13 Quid has not shown that monetary relief would be inadequate, arguing only that injunctive relief is
14 available for trade secret claims.9 But the alleged trade secrets here are 2015 information
15 concerning products which have been on the market for years. Quid has not shown monetary
16 damages are insufficient redress its claims where both parties are selling products in the
17 marketplace.
20 product development to stay afloat. Gourley Decl. at ¶¶ 44, 84. In assessing an injunction, this
21 Court must balance these potential hardships against those of Quid. “The ultimate goal of any test
22 to be used in deciding whether a preliminary injunction should issue is to minimize the harm
23 which an erroneous interim decision may cause.” IT Corp. v. Cty. of Imperial, 35 Cal. 3d 63, 73
24 (1983). Here it is only Primer who is truly at risk of suffering irreparable harm which means Quid
25
9
The possibility of injunctive relief referenced in Dr. Gourley’s employment contract does not
26 bind Primer and would not control here even if it did. See DVD Copy Control Ass’n, Inc. v.
Kaleidescape, Inc., 176 Cal. App. 4th 697 (2009) (“[A] court must reject a stipulation
27
contemplating an equitable remedy that is contrary to law or public policy, such as where the
28 evidence shows that an aggrieved party actually has an adequate remedy at law.”).
6 extent that the solicitation relies on a trade secret customer list. Galante, 176 Cal. App. 4th at
7 1238-40 (citing Edwards and Cal. Bus. & Prof. Code § 16600, supra). Quid admitted at the
8 March 28 hearing they have no such list, nor could they as their customers are publicly disclosed
9 as discussed supra. Moreover, under the recent decision of AMN Healthcare, Inc. v. Aya
10 Healthcare Services, Inc. (2018) 28 Cal.App.5th 923, 939, “California law is properly interpreted
12 2019 WL 176260, at *3 (N.D. Cal. Jan. 11, 2019) (citing AMN). For the same reasons, a customer
14 This is yet another instance of Quid attempting to craft an injunction that is contrary to California
28 $54.7M).
4
By Jordan R. Jaffe
5 Jordan R. Jaffe
Attorneys for PRIMER TECHNOLOGIES, INC.
6
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28